Related Experiment Videos
[Directly observed therapy (DOT): from tuberculosis to HIV]
1Centre Hospitalier Universitaire McGill, Université McGill, Montréal, Québec, Canada. mmachouf@lactuel.ca
Revue D'Epidemiologie Et De Sante Publique
|April 13, 2006
Summary
Directly observed therapy may improve adherence to antiretroviral treatment for HIV patients. This strategy, where medication is taken under supervision, shows promise in managing viral load and treatment regimens.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Context:
- Combination antiretroviral therapy (ART) is standard HIV care since 1996.
- Optimal ART benefit requires strict patient adherence to treatment regimens.
- Non-adherence is a significant challenge in managing HIV.
Purpose:
- To review the efficacy of directly observed therapy (DOT) in improving adherence to antiretroviral treatment for HIV patients.
- To assess the feasibility and impact of DOT on viral load control in HIV management.
Summary:
- A literature search identified 25 papers (1996-2004) on DOT for HIV, primarily from industrialized nations.
- Most studies focused on non-adherent patients or intravenous drug users, with a majority showing improved adherence or viremia control with DOT.
- Few studies were comparative, and only one randomized trial was found.
Impact:
- DOT appears to be a feasible strategy for enhancing adherence in HIV patients struggling with non-adherence.
- Further clinical trials are necessary to definitively establish the efficacy of DOT in improving antiretroviral adherence and patient outcomes.